Search research articles
Contact Us
Filters
Showing results (531-540 of 742) with videos related to
Page
of 75
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
January 9, 2024
Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: Incidence, clinical management, and outcome
Elisa Balletto, Marta Ponzano, Anna Maria Raiola, et al.
Frontiers in Medicine
|
January 26, 2023
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19
Federico Baldi, Chiara Dentone, Malgorzata Mikulska, et al.
Journal of Global Antimicrobial Resistance
|
May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
Critical Care (London, England)
|
October 29, 2024
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials
Patrick M Honoré, Massimo Girardis, Marin Kollef, et al.
Infectious Diseases and Therapy
|
June 3, 2024
Opportunities to Enhance Diagnostic Testing and Antimicrobial Stewardship: A Qualitative Multinational Survey of Healthcare Professionals
Timothy Jinks, Sumithra Subramaniam, Matteo Bassetti, et al.
Journal of Medical Virology
|
April 29, 2021
Characterization of T lymphocytes in severe COVID-19 patients
Daniela Fenoglio, Chiara Dentone, Alessia Parodi, et al.
European Journal of Internal Medicine
|
September 13, 2021
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care
Lucia Taramasso, Laura Magnasco, Federica Portunato, et al.
The Lancet. Infectious Diseases
|
October 15, 2020
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Matteo Bassetti, Roger Echols, Yuko Matsunaga, et al.
The Lancet. Infectious Diseases
|
December 24, 2019
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial
Michael S Niederman, Jeff Alder, Matteo Bassetti, et al.
Critical Care (London, England)
|
June 3, 2014
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study
Stijn Blot, Despoina Koulenti, Murat Akova, et al.
Page
of 75
Search research articles
Search
Showing results (531-540 of 742) with videos related to
Sort By:
Page
of 75
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
January 9, 2024
Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: Incidence, clinical management, and outcome
Elisa Balletto, Marta Ponzano, Anna Maria Raiola, et al.
Frontiers in Medicine
|
January 26, 2023
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19
Federico Baldi, Chiara Dentone, Malgorzata Mikulska, et al.
Journal of Global Antimicrobial Resistance
|
May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
Critical Care (London, England)
|
October 29, 2024
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials
Patrick M Honoré, Massimo Girardis, Marin Kollef, et al.
Infectious Diseases and Therapy
|
June 3, 2024
Opportunities to Enhance Diagnostic Testing and Antimicrobial Stewardship: A Qualitative Multinational Survey of Healthcare Professionals
Timothy Jinks, Sumithra Subramaniam, Matteo Bassetti, et al.
Journal of Medical Virology
|
April 29, 2021
Characterization of T lymphocytes in severe COVID-19 patients
Daniela Fenoglio, Chiara Dentone, Alessia Parodi, et al.
European Journal of Internal Medicine
|
September 13, 2021
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care
Lucia Taramasso, Laura Magnasco, Federica Portunato, et al.
The Lancet. Infectious Diseases
|
October 15, 2020
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Matteo Bassetti, Roger Echols, Yuko Matsunaga, et al.
The Lancet. Infectious Diseases
|
December 24, 2019
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial
Michael S Niederman, Jeff Alder, Matteo Bassetti, et al.
Critical Care (London, England)
|
June 3, 2014
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study
Stijn Blot, Despoina Koulenti, Murat Akova, et al.
Page
of 75